An observational study of blood concentrations and kinetics of methyl- and propyl-parabens in neonates

Pharmaceutical Research

Volumn 32, Issue 3, 2015, Pages 1084-1093

  Mulla, H ^a,j   Yakkundi, S ^b   McElnay, J ^b   Lutsar, I ^c   Metsvaht, T ^c,d   Varendi, H ^e   Nellis, G ^c,e   Nunn, A ^f   Duncan, J ^f   Pandya, H ^g   Turner, M ^h,i  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY OF TARTU   (Estonia)

^d TARTU UNIVERSITY HOSPITAL   (Estonia)

^e TARTU UNIVERSITY HOSPITAL   (Estonia)

^f ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY OF LEICESTER   (United Kingdom)

^h LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF LIVERPOOL   (United Kingdom)

^j GLENFIELD HOSPITAL   (United Kingdom)

more..

Author keywords

exicipient; kinetics; methyl parabens; neonates; propyl parabens

Indexed keywords

METHYL PARABEN; PROPYL PARABEN; 4 HYDROXYBENZOIC ACID ESTER; EXCIPIENT;

ADSORPTION KINETICS; ARTICLE; BLOOD; BLOOD LEVEL; DRIED BLOOD SPOT TESTING; DRUG BIOAVAILABILITY; DRUG CLEARANCE; EXPOSURE; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; NEWBORN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; BIOAVAILABILITY; BIOLOGICAL MODEL; CLINICAL TRIAL; COMPUTER SIMULATION; DRUG ADMINISTRATION; ENGLAND; ESTONIA; GESTATIONAL AGE; MEDICINAL CHEMISTRY; METABOLIC CLEARANCE RATE; MULTICENTER STUDY; NONLINEAR SYSTEM; ORAL DRUG ADMINISTRATION; PREMATURITY; RISK ASSESSMENT; TERM BIRTH;

ADMINISTRATION, ORAL; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; COMPUTER SIMULATION; DRIED BLOOD SPOT TESTING; DRUG ADMINISTRATION SCHEDULE; ENGLAND; ESTONIA; EXCIPIENTS; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; NONLINEAR DYNAMICS; PARABENS; RISK ASSESSMENT; TERM BIRTH;

EID: 84925485183     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-014-1520-2     Document Type: Article

References (33)

1. Pifferi G, Santoro P, Pedrani M. Quality and functionality of excipients. Farmaco. 1999;54(1-2):1-14.
2. MacDonald MG, Getson PR, Glasgow AM, et al. Propylene glycol: increased incidence of seizures in low birth weight infants. Pediatrics. 1987;79:622-5.
3. Gershanik J, Boecler B, Ensley H, et al. The gasping syndrome and benzyl alcohol poisoning. N Engl J Med. 1982;307:1384-8.
4. Lopez-Herce J, Bonet C, Meana A, et al. Benzyl alcohol poisoning following diazepam intravenous infusion (letter). Ann Pharmacother. 1995;29:632.
5. Drug Safety Communication: Serious health problems seen in premature babies given Kaletra (lopinavir/ritonavir) oral solution.; FDA (2011). Available from: http://www.fda.gov/Drugs/DrugSafety/ucm246002.htm. Accessed 12/15/2014.
6. Shehab N, Lewis CL, Streetman DD, et al. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. Pediatr Crit Care Med. 2009;10:256-9.
7. Whittaker A, Currie AE, Turner MA, et al. Toxic additives in medications for preterm infants. Arch Dis Child Fetal Neonatal Ed. 2009;94:236-40.
8. Souza A Jr, Santos D, Fonseca S, Medeiros M, Batista L, Turner M, Coelho H. Toxic excipients in medications for neonates in Brazil. Eur J Pediatr. 2014 Feb 6. [Epub ahead of print].
9. EMEA/CHMP/PEG/194810/2005 (2006) Reflection paper: formulations of choice for the paediatric population. Available from: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/09/WC500003782.pdf. Accessed 12 May 2013.
10. Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. London: Pharmaceutical Press; 2009.
11. Routledge EJ, Parker J, Odum J, Ashby J, Sumpter JP. Some Alkyl Hydroxy Benzoate Preservatives (Parabens) Are Estrogenic. Toxicol Appl Pharmacol. 1998;153:12-9.
12. Oishi S. Effects of butylparaben on the male reproductive system in rats. Toxicol Indust Health J. 2001;17:31-9.
13. Oishi S. Effects of butyl paraben on the male reproductive system in mice. Arch Toxicol. 2002;76:423-9.
14. Oishi S. Effects of propyl paraben on the male reproductive system. Food Chem Toxicol. 2002;40:1807-13.
15. Oishi S. Lack of spermatotoxic effects of methyl and ethyl esters of p-hydroxybenzoic acid in rats. Food Chem Toxicol. 2004;42:1845-9.
16. Hoberman AM et al. Lack of effect of butylparaben and methylparaben on the reproductive system in male rats. Birth Defects Res (Part B). 2008;83:123-33.
17. Gazin V, Marsden E, Marguerite F. Oral propylparaben administration to juvenile male Wistar rats did not induce toxicity in reproductive organs. Toxicol Sci. 2013;136(2):392-401.
18. EMA/CHMP/SWP/272921/2012 2. Reflection paper on the use of methyl- and propylparaben as excipients in human medicinal products for oral use. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general-content-000400.jsp&mid=WC0b01ac0580029570. Accessed 12 May 2014.
19. Johnson TN, Rostami-Hodjegan A, Tucker GT. Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children. Clin Pharmacokinet. 2006;45:931-56.
20. Aubert N, Ameller T, Legrand JJ. Systemic exposure to parabens: pharmacokinetics, tissue distribution, excretion balance and plasma metabolites of [14C]-methyl-, propyl- and butylparaben in rats after oral, topical or subcutaneous administration. Food Chem Toxicol. 2012;50(3-4):445-54.
21. Frederiksen H, Jørgensen N, Andersson A-M. Parabens in urine, serum and seminal plasma from healthy Danish men determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS). J Expo Sci Environ Epidemiol. 2011;21:262-71.
22. Sandanger T, Huber S, Moe MK, Braathen T, Leknes H, Lund E. Plasma concentrations of parabens in postmenopausal women and self-reported use of personal care products: the NOWAC postgenome study. J Expo Sci Environ Epidemiol. 2011;21:595-600.
23. Yakkundi S, McElnay J, Millership J, Mulla H, Pandya H, Shah U, et al. Use of dried blood spots to study excipient kinetics in neonates. Bioanalysis. 2011;3(24):2691-3.
24. Sheiner LB, Rosenberg B, Marathe V. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm. 1977;5:445-79.
25. Ahn JE, Karlsson MO, Dunne A, Ludden TM. Likelihood based approaches to handling data below the quantification limit using NONMEM VI. J Pharmacokinet Pharmacodyn. 2008;35(4):401-21.
26. Savic RM, Jonker DM, Kerbusch T, Karlsson MO. Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies. J Pharmacokinet Pharmacodyn. 2007;34(5):711-26.
27. Patel P, Mulla H, Kairamkonda V, Spooner N, Gade S, Della Pasqua O, et al. Dried blood spots and sparse sampling: a practical approach to estimating pharmacokinetic parameters of caffeine in preterm infants. Br J Clin Pharmacol. 2013;75(3):805-13.
28. Schlumpf M, Kypke K, Wittassek M, Angerer J, Mascher H, Mascher D, et al. Exposure patterns of UV filters, fragrances, parabens, phthalates, organochlor pesticides, PBDEs, and PCBs in human milk: correction of UV filters with use of cosmetics. Chemosphere. 2010;81:1171-83.
29. Darbre PD, Aljarrah A, Miller WR, Coldham NG, Sauer MJ, Pope GS. Concentrations of parabens in human breast tumours. J Appl Toxicol. 2004;24:5-13.
30. Janjua NR, Frederiksen H, Skakkeback NE, Wulff HC, Andersson AM. Urinary excretion of phthalates and paraben after repeated whole-body topical application in humans. Int J Androl. 2008;31:118-30.
31. Tsukamoto H, Terada S. Metabolism of drugs. XXVI Metabolic fate of p-hydroxybenzoic acid and its derivatives in rabbits. Chem Pharm Bull. 1962;10:86-90.
32. Yang D, Pearce RE, Wang X, Gaedigk R, Wan YJ, Yan B. Human carboxylesterases HCE1 and HCE2: Ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin. Biochem Pharmacol. 2009;77:238-47.
33. Zhu HJ, Appel DI, Jiang Y, Markowitz JS. Age- and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver. Drug Metab Dispos. 2009;37(9):1819-25.